LIDDiA introduces an autonomous AI agent capable of navigating the complex drug discovery process that traditionally takes years and relies heavily on human expertise.

• Independently navigates the entire drug discovery workflow
• Intelligently searches vast chemical spaces for potential therapies
• Addresses the pharmaceutical industry's need for accelerated discovery processes
• Demonstrates application for clinical targets including EGFR for cancer treatments

This research represents a significant advancement for the medical field by potentially reducing development timelines and costs for new therapeutics, while maintaining the scientific rigor needed for pharmaceutical development.

LIDDIA: Language-based Intelligent Drug Discovery Agent